• Mashup Score: 0
    3D Echocardiography in Heart Failure and Valvular Disease - 7 month(s) ago

    The aim of this workshop is to discuss important topics within the vast field of heart failure and valvular heart disease with experts in the field. We will highlight the use of 3D echocardiography in special clinical settings from guiding medical therapy to mechanical support. Furthermore we will focus on the use of 3D within the growing field of valvular heart disease. The speakers will not only concentrate on the assigned topics but will also offer a comprehensive step by step approach to the dedicated use of 3D echocardiography by showing their tips and tricks. In optional hands-on sessions, we will give insights on acquisition rules and application. It is mandatory to share our secrets on how the magic happens in the post-processing process. Hence, you will get the opportunity to work on real dataset using the workstation (GE EchoPAC) on day 3.

    Source: buchung.dhzb-akademie.de
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NMerke
      NMerke

      #echofirst year 2023 is fading away, Xmas incoming Time to prepare #echofirst year 2024: Starting strong #3DEchoBerlin & ending even stronger #EuroEcho24Berlin Me organizing: 🫶 #3DEchoBerlin 3D Workshop #HF #VHD 👊Register here: https://t.co/prs2NYyHZb 🫶 German teaching… https://t.co/2r3PeH5UbL

  • Mashup Score: 7
    Home - 7 month(s) ago

    Heart failure (HF) is a major cause of morbidity and mortality in the United States, with a prevalence that is expected to increase from about 6 million today to more than 8 million by 2030. A growing body of evidence pinpoints iron deficiency (ID) as an important comorbidity of HF, affecting more than 50% of patients with stable HF. Although the correction of ID is critical to improve outcomes in patients with HF, clinicians often overlook ID when providing HF care. Join our panel of experts for an

    Source: na.eventscloud.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of theheartorg
      theheartorg

      🚨 1 WEEK LEFT: Don't miss this event at #HFSA2023 October 7, 2023. Join experts @KPHeartDoc, @GLewisCardiol and @noshreza as they discuss 🗣️ how to recognize and manage ID in patients with chronic #Heartfailure. Secure your seat now: https://t.co/G3qtZyHB9A #cardiotwitter #HF https://t.co/4JV8Sv8HbW

    • Profile photo of MedscapeDerm
      MedscapeDerm

      Don't miss this event at #HFSA2023 October 7, 2023. Join experts @KPHeartDoc, @GLewisCardiol and @noshreza as they discuss 🗣️ how to recognize and manage ID in patients with chronic #Heartfailure. Secure your seat now: https://t.co/Tw2cXQDDhJ #cardiotwitter #HF https://t.co/Xk5AQ6O2K4

  • Mashup Score: 2
    Home - 7 month(s) ago

    Heart failure (HF) is a major cause of morbidity and mortality in the United States, with a prevalence that is expected to increase from about 6 million today to more than 8 million by 2030. A growing body of evidence pinpoints iron deficiency (ID) as an important comorbidity of HF, affecting more than 50% of patients with stable HF. Although the correction of ID is critical to improve outcomes in patients with HF, clinicians often overlook ID when providing HF care. Join our panel of experts for an

    Source: na.eventscloud.com
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MedscapeDerm
      MedscapeDerm

      Don't miss this event at #HFSA2023 October 7, 2023. Join experts @KPHeartDoc, @GLewisCardiol and @noshreza as they discuss 🗣️ how to recognize and manage ID in patients with chronic #Heartfailure. Secure your seat now: https://t.co/cecwI4EwKl #cardiotwitter #HF https://t.co/ZHwfIPRVrM

  • Mashup Score: 0
    Home - 7 month(s) ago

    Heart failure (HF) is a major cause of morbidity and mortality in the United States, with a prevalence that is expected to increase from about 6 million today to more than 8 million by 2030. A growing body of evidence pinpoints iron deficiency (ID) as an important comorbidity of HF, affecting more than 50% of patients with stable HF. Although the correction of ID is critical to improve outcomes in patients with HF, clinicians often overlook ID when providing HF care. Join our panel of experts for an

    Source: na.eventscloud.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of theheartorg
      theheartorg

      🚨 1 WEEK LEFT: Don't miss this event at #HFSA2023 October 7, 2023. Join experts @KPHeartDoc, @GLewisCardiol and @noshreza as they discuss 🗣️ how to recognize and manage ID in patients with chronic #Heartfailure. Secure your seat now: https://t.co/OO58QLawqx #cardiotwitter #HF https://t.co/h5r9rLc952

    • Profile photo of MedscapeDerm
      MedscapeDerm

      Don't miss this event at #HFSA2023 October 7, 2023. Join experts @KPHeartDoc, @GLewisCardiol and @noshreza as they discuss 🗣️ how to recognize and manage ID in patients with chronic #Heartfailure. Secure your seat now: https://t.co/RQSXJCu7pt #cardiotwitter #HF https://t.co/woJs9CsH5v

Load More